Lifeward Ltd. Returns to Nasdaq Audit Committee Compliance Following Director Resignation

Key Points:

• Lifeward Ltd. (NASDAQ: LFWD) recently received and resolved a compliance deficiency notice from the Nasdaq Stock Market related to its Audit Committee composition.
• The deficiency arose due to the resignation of Board and Audit Committee member Hadar Levy, leaving the Audit Committee with fewer than the required three members.
• Nasdaq Listing Rule 5605(c)(2)(A) mandates that listed companies maintain an audit committee of at least three members.
• Nasdaq granted Lifeward a cure period to regain compliance, with deadlines aligned to the company’s next annual shareholder meeting or specific calendar dates.
• On March 30, 2026, Lifeward notified Nasdaq of the appointment of Moshe Rozenbaum, William Mark Sigsbee, and Yehuda Reznick to its Audit Committee, restoring compliance.
• Nasdaq confirmed the company’s compliance and closed the matter.

Detailed Article for Investors

Lifeward Ltd., a company listed on the Nasdaq Capital Market (trading symbol: LFWD), reported a significant corporate governance event that may be of interest to investors and shareholders. On March 30, 2026, the company disclosed that it had received a written notice from the Nasdaq Listing Qualifications Department, alerting them to a breach of a key listing rule: Nasdaq Listing Rule 5605(c)(2)(A).

This rule requires companies listed on the Nasdaq to have an audit committee comprised of at least three independent directors. The breach occurred following the resignation of Hadar Levy from both Lifeward’s Board of Directors and its Audit Committee. With Levy’s departure, the Audit Committee fell below the minimum member threshold, triggering a compliance deficiency notice.

The Nasdaq notice also laid out a cure period for Lifeward to restore compliance. The company was required to appoint a new committee member by the earlier of the next annual shareholder meeting or February 24, 2027. However, if the next annual meeting was scheduled before August 24, 2026, Lifeward would need to demonstrate compliance no later than that date.

On March 30, 2026, Lifeward acted promptly and confirmed the appointment of three members to its Audit Committee: Moshe Rozenbaum, William Mark Sigsbee, and Yehuda Reznick. This move restored the committee to full compliance with Nasdaq’s requirements. Shortly thereafter, Nasdaq acknowledged the company’s action, confirmed that compliance had been restored, and closed the matter.

Implications for Shareholders:

• The resolution of the compliance deficiency is crucial for Lifeward Ltd.’s continued listing on the Nasdaq Capital Market. Delisting or ongoing compliance issues could negatively impact share value, shareholder confidence, and liquidity.
• The swift and transparent response by Lifeward’s management may reassure investors regarding corporate governance standards and the company’s commitment to regulatory compliance.
• While this event is not directly related to financial performance, governance matters and exchange compliance are considered price-sensitive as they can affect the company’s reputation, risk profile, and access to capital markets.

Other Information:

• Ordinary Shares of Lifeward Ltd. (LFWD) continue to be traded on the Nasdaq Capital Market.
• There were no indications that the company is an emerging growth company, nor any written or soliciting communications, or pre-commencement tender offers disclosed in the filing.

Disclaimer:
This article is based on Lifeward Ltd.’s SEC Form 8-K filing dated March 30, 2026. It is intended for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult a professional advisor before making investment decisions. Company events related to governance and regulatory compliance may impact share price, but other factors should also be considered.

View Lifeward Ltd. Historical chart here